Evaluating Traditional Medicine Syndromes in Male Infertility With Oligoasthenoteratozoospermia

Inclusion Criteria: * Male patients aged between 18 and 60 years. * Diagnosed with male infertility by an andrology specialist according to World Health Organization (WHO) standards. * Semen analysis results meet the diagnostic criteria for Oligoasthenoteratozoospermia (OAT) syndrome. * Voluntary agreement to participate in the research and signed Informed Consent Form. Exclusion Criteria: * Infertility caused by genetic or chromosomal abnormalities, including but not limited to: Klinefelter syndrome, Sandberg mosaic syndrome (46 XY/47 XXY), or XYY syndrome. * Presence of structural abnormalities of the reproductive organs. * Patients with Azoospermia (absence of sperm in the ejaculate) as defined by WHO 2021 standards. * Use of medications affecting spermatogenesis within the last 3 months, including: cannabinoids, hydantoins, valproate, anabolic steroids, cimetidine, colchicine, spironolactone, nitrofurantoin, sulfasalazine, or calcium channel blockers. * Inability to understand or answer survey questions due to physical or mental limitations (e.g., mutism, deafness, intellectual disability, coma, or being on a ventilator in the ICU). * Lack of cooperation during the clinical examination and interview process.